1 of 1
HOUSE DOCKET, NO. 2992 FILED ON: 1/16/2025
HOUSE . . . . . . . . . . . . . . . No. 193
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Marcus S. Vaughn
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act to improve warning labels on THC products.
_______________
PETITION OF:
NAME:DISTRICT/ADDRESS :DATE ADDED:Marcus S. Vaughn9th Norfolk1/16/2025 1 of 2
HOUSE DOCKET, NO. 2992 FILED ON: 1/16/2025
HOUSE . . . . . . . . . . . . . . . No. 193
By Representative Vaughn of Wrentham, a petition (accompanied by bill, House, No. 193) of
Marcus S. Vaughn relative to warning labels on products containing cannabis. Cannabis Policy.
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Fourth General Court
(2025-2026)
_______________
An Act to improve warning labels on THC products.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 SECTION 1. Subsection (a1/2) of section 4 of chapter 94G of the General Laws is hereby
2amended by striking clause (xxvi) and inserting in place thereof the following:
3 (xxvi) requirements for the labeling of a package containing marijuana or marijuana
4products that shall, at a minimum, include: (1) a symbol or easily recognizable mark issued by
5the commission that indicates the package contains marijuana or a marijuana product; (2) a
6symbol or other easily recognizable mark issued by the commission on the package indicating to
7children that the product is harmful to children; (3) the name and contact information of the
8marijuana cultivator or the marijuana product manufacturer who produced the marijuana or
9marijuana product; (4) the results of sampling, testing and analysis conducted by a licensed
10independent testing laboratory; (5) a seal certifying the marijuana meets such testing standards;
11(6) a unique batch number identifying the production batch associated with manufacturing,
12processing, and cultivating; (7) a list of ingredients and possible allergens; (8) in bold, the
13amount of delta-nine-tetrahydrocannabinol (Δ9–THC) in the package and in each serving of a 2 of 2
14marijuana product as expressed in absolute terms and as a percentage of volume; (9) the number
15of servings in a package if there are multiple servings; (10) a use-by date, if applicable; and (11)
16the following statement, including capitalization: ''This product has not been analyzed or
17approved by the FDA. There is limited information on the side effects of using this product, and
18there may be associated health risks. Marijuana use during pregnancy and breast-feeding may
19pose potential harms. It is against the law to drive or operate machinery when under the
20influence of this product. KEEP THIS PRODUCT AWAY FROM CHILDREN.''; and (12)
21comprehensive prominent rotating health warnings, based on the best available research on what
22constitutes effective warnings for transmitting knowledge and achieving behavior change from
23tobacco and cannabis warning research, including pictorial warnings if supported. These
24regulations shall be periodically updated based on emerging science on cannabis and on warning
25communication best practices. These warnings must also include the increased risk of
26cannabinoid hyperemesis syndrome, cannabis use disorder, mood disorders, psychosis described
27as paranoia, hallucinations, delusions, schizophrenia , and suicidal thoughts with use of THC-
28containing marijuana products, especially when initiated young, used frequently, and/or with use
29of products containing more than 10% THC.